The global portable bioprocessing bioreactors market is witnessing rapid growth, valued at USD 2.95 billion in 2024 and projected to surge to USD 7.25 billion by 2034 at a CAGR of 9.37% (2025-2034).
This expansion is fueled by the increasing demand for flexible and scalable biomanufacturing systems suitable for biologics, cell and gene therapies, and personalized medicines. Key drivers include technological advancements such as automation and single-use technologies, and the rise of CDMOs and biomanufacturing expansion in emerging economies.
Market Size (2024): USD 2.95 billion
Projected Size (2034): USD 7.25 billion
CAGR (2025–2034): 9.37%
Leading Region: North America (31.5% revenue share in 2024)
Fastest-Growing Region: Asia-Pacific
Top Segment (System Type): Single-use portable bioreactors (41% share)
Top Segment (Capacity): 1-10L
About: A global leader in scientific services, Thermo Fisher specializes in laboratory and bioprocessing solutions.
Products: HyPerforma single-use bioreactors, fermenters, and process monitoring systems.
Market Cap: Approx. USD 190 billion.
About: Sartorius focuses on bioprocessing and lab equipment, driving innovations in single-use technologies.
Products: Ambr and BIOSTAT series bioreactors, filtration systems.
Market Cap: Approx. USD 30 billion.
About: A prominent science and technology company, Merck is at the forefront of bioprocessing advancements.
Products: Mobius single-use bioreactors, bioprocessing hardware, and consumables.
Market Cap: Approx. USD 95 billion.
About: Known for lab automation and bioreactor technologies, Eppendorf supports scalable biomanufacturing.
Products: BioFlo bioreactors, fermenters, and cell culture solutions.
Market Cap: Private company; estimated revenues exceed USD 1 billion.
About: Danaher’s diverse portfolio includes life sciences and diagnostics, supporting global bioprocessing demand.
Products: Pall and Cytiva bioprocessing systems.
Market Cap: Approx. USD 200 billion.
About: A key player in healthcare technologies, GE’s Cytiva division leads in bioprocessing equipment.
Products: Xcellerex single-use bioreactors and FlexFactory solutions.
Market Cap: Approx. USD 30 billion (Cytiva as part of Danaher).
About: Specializes in laboratory and analytical equipment with a growing presence in bioprocessing.
Products: Bioreactors, fermenters, and mixing systems.
Market Cap: Private company.
About: A niche provider of lab and bioprocessing equipment with a focus on compact systems.
Products: Bench-top bioreactors and cell culture devices.
Market Cap: Private company.
About: Innovator in single-use bioreactors for advanced cell therapy manufacturing.
Products: Vertical-Wheel bioreactors.
Market Cap: Private company.
About: Part of Danaher, Pall offers a wide range of bioprocessing solutions.
Products: Single-use systems, filtration devices.
Market Cap: Integrated within Danaher.
About: Known for compact and portable bioprocessing solutions tailored for research and industry.
Products: Genesis and Jupiter bioreactor lines.
Market Cap: Private company.
About: Focuses on advanced bioreactor systems for R&D and production.
Products: Applikon BIOSTAT and EZ-Control bioreactors.
Market Cap: Part of Getinge Group.
About: Offers bioprocessing solutions for pharmaceutical and biotechnology applications.
Products: BIOne single-use bioreactors and accessories.
Market Cap: Private company.
About: Specializes in motion and control technologies with applications in bioprocessing.
Products: Bioprocess filtration and control systems.
Market Cap: Approx. USD 55 billion.
About: Delivers materials and consumables for biopharma manufacturing.
Products: Bioprocess tubing, connectors, and single-use assemblies.
Market Cap: Approx. USD 18 billion.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
The demand for flexible and scalable solutions in biologics, cell therapies, and personalized medicine is fueling market growth.
North America holds the largest market share, accounting for 31.5% of revenue in 2024.
They reduce contamination risks, lower operational costs, and support rapid process scale-up.
Top companies include Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Danaher Corporation, and GE Healthcare.
The market is projected to grow at a CAGR of 9.37% between 2025 and 2034.
Source : https://www.towardshealthcare.com/insights/portable-bioprocessing-bioreactors-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5855
The global stem cell reconstructive market is on a remarkable growth trajectory. Valued at USD 1.56 billion in 2024, it… Read More
The global cell viability assays market is witnessing robust growth, valued at USD 1.89 billion in 2024, rising to USD… Read More
The global immortalized cell line market was valued at USD 4.55 billion in 2024, expected to grow to USD 4.85… Read More
The global live cell imaging market is on an impressive growth trajectory, valued at USD 2.92 billion in 2024 and… Read More
The global stem cell assay market is experiencing significant expansion, growing from USD 2.68 billion in 2024 to a projected… Read More
The global bioburden testing market is witnessing unprecedented growth, fueled by advancements in biopharmaceutical industries, rising infectious disease cases, and… Read More